Skip to content
value.today

Lysogene vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $4 M for Lysogene, 22533 times as much (market caps of Dec 25, 2022 for Lysogene and Oct 30, 2026 for Moderna, Inc.). Lysogene's value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
  • Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $4 M for Lysogene in the year to December 2021.
  • Both made a net loss: $16 M for Lysogene and $2.8 B for Moderna, Inc.
  • Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -364.9% for Lysogene.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Lysogene 14Moderna, Inc. 1370

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Lysogene $0BModerna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureLysogene
LYS.PA
Moderna, Inc.
MRNA · #275 in the world
Profile
Country🇫🇷 France🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded—2010
Size
Market cap$4 M*$90.1 B
Revenue$4 M$1.9 B
Net income$-16 M▲ best$-2.8 B
Employees—4,700
Valuation
Price to sales—35.7×
Price to book—10.4×
Free cash flow yield—-2.3%
Profitability
Gross margin—55.4%
Operating margin—-158.1%
Net margin—-145.2%
Return on equity—-28.9%
Growth
Revenue growth—-39.9%
Revenue growth, 3 years a year—-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin—-106.2%
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zone—safe
Data as ofMarket cap Dec 2022Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Lysogene or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $4 M for Lysogene, 22533 times as much (market caps of Dec 25, 2022 for Lysogene and Oct 30, 2026 for Moderna, Inc.). Lysogene's value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, Lysogene or Moderna, Inc.?

Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $4 M for Lysogene in the year to December 2021. Both made a net loss: $16 M for Lysogene and $2.8 B for Moderna, Inc.

Which is more profitable, Lysogene or Moderna, Inc.?

Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -364.9% for Lysogene.

Sources#

Every figure on this page comes from these, with the date shown next to it.